Arthur M. Sutherland Award and Memorial Lecture
Bernard Fox Memorial Award
- 2026 – Patricia Parker (USA)
Dr. Parker has made outstanding contributions to psycho-oncology over the past 28 years. Her work includes training more than 5,000 oncology care professionals and holding key leadership roles at institutional, national, and international levels. She has served as chair and co-chair for several psycho-oncology programs. Her leadership of the MSK Comskil Program has had substantial institutional and international impact, with extensive training reach and strong integration of research and clinical practice. She has an impressive publication record, consistent extramural funding, and a sustained commitment to mentorship and leadership within IPOS. With multiple impactful publications and sustained contributions to both education and research, she emerges very deserving of this award.
- 2025 – Joanne Shaw (Australia)
- 2024 – Sophie Lebel (Canada)
- 2023 – Anja Mehnert-Theuerkauf (Germany)
- 2022 – Dr. Electra Paskett (USA)
- 2020/2021 – Dr. Mary Jane Esplen (Canada)
- 2019 – Dr. Linda Carlson (Canada)
- 2018 – Professor Brian Kelly (Australia)
- 2017 – Dr. Gary Rodin (Canada)
- 2016 – Kimlin Tam Ashing (USA)
- 2015 – Dr. Susan Okjsberg Dalton (Denmark)
- 2014 – Julia Rowland (USA)
- 2013 – Hanneke de Haes
- 2012 – Darius Razavi*
- 2011 – Christoffer Johansen (Denmark)
- 2010 – Harvey Max Chochinov (Canada)
- 2009 – Phyllis Butow (Australia) and Ruth McCorkle
- 2008 – Paul Jacobsen (USA)
- 2007 – Joan Bloom (USA)
- 2006 – Yosuke Uchitomi (Japan)
- 2004 – Neil Aaronson (Netherlands) and David Cella
- 2003 – Lydia Temoshok
Jimmie Holland Memorial Award Winner
-
2026 – Elisabeth Andritsch (Austria)
Elisabeth has an impressive 35-year career in clinical care, research, and contributions to the promotion and growth of psycho-oncology in her region. This prestigious award recognizes individuals whose unique, innovative, and pioneering contributions have substantially advanced the field of psycho-oncology. Elisabeth is a true pioneer—not only within Austria but also on the international stage. Her work has been instrumental in shaping and advancing psycho-oncology as an essential component of cancer care. The extensive evidence of her tireless efforts to integrate psycho-oncology into routine cancer care reflects a deep and sustained commitment to the core mission of IPOS. Her leadership, vision, and impact make her an exceptionally deserving recipient of this award.
2025 – Luigi Grassi (Italy)
-
2024 – Lea Baider (Israel)
-
2023 – Maggie Watson (UK)
-
2022 – Dr. Luzia Travado (Portugal)
- 2020/2021 – Chioma Asuzu (Nigeria)
- 2019 – William Breitbart (USA)
SPECIAL AWARDS
- 2006 – Aruna Tole, Special Award for Outstanding Contributions to Clinical Care of Patients with Cancer
| |
Hiroomi & Setsuko Kawano New Investigator Award
- 2026 – Darren Haywood (Australia)
Dr. Haywood stands out as an emerging leader in psycho-oncology and is highly deserving of The Hiroomi & Setsuko Kawano New Investigator Award. His work has made significant contributions in two key areas. First, he has advanced understanding of the lived experience of individuals affected by cancer-related cognitive impairment (CRCI). This program of research led to the development of COG-IMPACT, the first and only assessment tool designed to identify unmet psychosocial needs associated with CRCI. The tool has already informed services across 12 countries and has supported more than 500,000 patients. Second, Dr. Haywood has contributed to improving how mental health difficulties are conceptualized in people affected by cancer. The field of psycho-oncology has long faced challenges related to psychological misdiagnosis, and he was the first to propose a viable solution through the application of the Hierarchical Taxonomy of Psychopathology (HiTOP) in cancer. This work introduced a dimensional framework that more accurately captures the complexity of cancer-related effects and associated psychopathology. Taken together, these accomplishments, along with a strong and growing publication record, active involvement in IPOS, and clear real-world impact, demonstrate both innovation and leadership.
- 2025 – Anna Singleton (Australia)
- 2024 – Jose Custers (The Netherlands)
- 2023 – William Rosa (USA)
- 2022 – Dr. Lauren Heathcote (UK/USA)
- 2020/2021 – Dr. Joanna Fardell (Australia)
- 2019 – Dr. Ursula Sansom-Daly (Australia)
- 2018 – Dr. Fiona Schulte, PhD (Canada)
- 2017 – Dr. Michelle Peate (Australia)
- 2016 – Dr. Shane Sinclair (Canada)
- 2015 – Dr. Katrina L Whittaker
- 2014 – Sylvie Lambert (Canada)
- 2013 – Mariko Asai
- 2012 – Wendy Lichtenthal (USA) and Claire Wakefield (Australia)
- 2011 – Nadine Kasparian (USA)
- 2010 – Maiko Fujimori (Japan)
- 2009 – Anja Mehnert (Germany) and Alex Mitchell (UK)
- 2008 – Susan T. Vadaparampil
- 2007 – Wendy Wing Tak Lam (Hong Kong)
- 2006 – Linda Carlson (Canada)
- 2004 – Bettina Meiser
- 2003 – Craig White
- 1998 – Christoffer Johansen (Denmark)
- 1996 – Yosuke Uchitomi (Japan)
- 1993 – Elizabeth Maunsell
Noemi Fisman Award for Lifetime Clinical Excellence
- 2026 – Michael Jefford (Australia)
Dr. Jefford has built an outstanding career over more than twenty years in clinical psycho-oncology and survivorship care, distinguished further by his contributions to research and education. As Consultant Medical Oncologist at the Peter MacCallum Cancer Centre and inaugural Director of the Australian Cancer Survivorship Centre (ACSC), he has led transformative initiatives that centre psychosocial wellbeing and holistic survivorship care. His early work included pioneering research on depression screening in oncology and palliative care. He has held major leadership roles across IPOS, COSA, MASCC, ASCO, and Cancer Council Victoria. Through these roles he has advanced communication training, survivorship models, and shaped national policy. Dr. Jefford has published more than 280 papers and 11 book chapters, and has defined unmet needs, quality of life outcomes, and intervention strategies for diverse survivor populations. He has built national survivorship education programs, producing more than 50 multilingual resources and ACSC training has reached over 26,000 health professionals. As founder and inaugural Chair of the IPOS Survivorship SIG, he enabled influential international studies. A dedicated mentor and widely invited speaker, he has shaped global survivorship discourse and is regarded as a highly deserving candidate for the Noemi Fisman Award.
- 2025 – Cristiane Decat Bergerot (Brazil)
- 2024 – Helen Greally (Ireland)
- 2023 – Gil Goldzweig (Israel)
- 2022 – Dr. Melissa Henry (Canada)
- 2020/2021 – Dr. Jong-Heun Kim (South Korea)
- 2018 – Dr. Lili Tang, MD (China)
- 2017 – Dr. Chun-Kai Fang
- 2015 – Dr. Andrew Roth (USA)
- 2014 – Matthew Loscalzo (USA)
- 2013 – Andrea Farkas Patenaude (USA)
- 2012 – David Wellisch
- 2011 – Marguerite Lederberg
- 2009 – Penelope Hopwood (UK)
- 2008 – Maria Die-Trill (Spain)
Society Distinguished Life Fellowship Award
President’s Community Award for Distinguished Contributions to IPOS
- 2019 – Kim Thiboldeaux, Chief Executive Officer, Cancer Support Community
- 2017 – Dr. Andreas Ullrich, WHO – Noncommunicable Diseases and Mental Health Cluster
- 2014 – Beth Diamond, President’s Community Award for Distinguished Contributions to IPOS
|
